The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV ... of PrEP saw a decrease in HIV infections, while rates continued rising elsewhere. About half of new infections are in women, ...

MIT's new dual-adjuvant vaccine offers strong HIV protection with a single dose, potentially aiding in the fight against challenging viruses.

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent ... PrEP saw a decrease in HIV infections, while rates continued rising elsewhere. About half of new infections are in ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It's the first step in an anticipated global rollout that could protect ...

The Food and Drug Administration has approved the world's only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday.